Novo Nordisk
NVO
#15
Rank
A$896.71 B
Marketcap
$202.30
Share price
2.14%
Change (1 day)
39.95%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$55.45 B

According to Novo Nordisk's latest financial reports the company's total liabilities are A$55.45 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novo Nordisk - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$45.19 B35.38%
2022-12-31A$33.38 B28.84%
2021-12-31A$25.91 B48.05%
2020-12-31A$17.50 B20.65%
2019-12-31A$14.50 B13.24%
2018-12-31A$12.81 B18.09%
2017-12-31A$10.84 B5.67%
2016-12-31A$10.26 B13.84%
2015-12-31A$9.01 B23.16%
2014-12-31A$7.32 B27.06%
2013-12-31A$5.76 B34.61%
2012-12-31A$4.28 B-7.52%
2011-12-31A$4.62 B7.48%
2010-12-31A$4.30 B5.22%
2009-12-31A$4.09 B-14.78%
2008-12-31A$4.80 B37.74%
2007-12-31A$3.48 B6.44%
2006-12-31A$3.27 B5.86%
2005-12-31A$3.09 B19.52%
2004-12-31A$2.58 B23.78%
2003-12-31A$2.09 B-7.24%
2002-12-31A$2.25 B-11.38%
2001-12-31A$2.54 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$192.31 B 246.77%๐Ÿ‡บ๐Ÿ‡ธ USA
A$87.35 B 57.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$116.35 B 109.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$91.25 B 64.55%๐Ÿ‡ซ๐Ÿ‡ท France